W
Wayspring
A Better Answer for Pain Care | axialHealthcare
About Wayspring
AxialHealthcare, a subsidiary of Wayspring, operates in the healthcare sector, specifically focusing on risk mitigation for patients with substance use disorders. The company has carved a niche for itself by providing a single, end-to-end solution that combines technology and human touch to improve both clinical and financial outcomes.
AxialHealthcare's primary clients are health insurance companies and healthcare providers. The company offers a suite of interactive tools that enable data-driven decision-making at the point of care. These tools provide patient intelligence, highlighting patients who fall into certain risk categories, such as those recommended for evaluation for substance use disorder, patients receiving opioids from multiple providers, or those using benzodiazepines with opioids.
The company's business model is centered around partnering with health insurance companies to offer these tools and resources to healthcare providers. This partnership allows providers to access patient-specific snapshots of key clinical information, an interactive opioid reduction tool, and insights into areas of patient risk within a set of clinical measures for opioid prescribing.
AxialHealthcare generates revenue through these partnerships with health insurance companies, who pay for the use of their risk mitigation tools and resources. The company's high-tech, high-touch approach, coupled with its wraparound patient support team, ensures that providers have the necessary resources to support the health and safety of patients on opioids.
Since 2017, AxialHealthcare has been successful in collaborating with multiple insurance companies, demonstrating its potential for growth and profitability in the healthcare sector.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | May 2024 | $45M | $375M | .406 Ventures · CVS Health Ventures · HLM Venture Partners · Valtruis | ↗ |
| LATE VCOther financing | Sep 2021 | $75M | $300M | HLM Venture Partners · Centene Corporation · Highmark Ventures · .406 Ventures | — |
Growth signals
Latest recorded traffic for Wayspring is 9.6K monthly website visits, up 31.5% over the last three months. Wayspring's team grew 3.5% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Wayspring in the Nashville ecosystem
The Wayspring office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Healthbox
BlueCross BlueShield Venture Partners
Healthcare Corporation of America
Series A4 investors entered at this stage
Blue Venture Fund
Sandbox Industries
.406 Ventures
Oak HC/FT
Series B and later7 investors entered at this stage
HLM Venture Partners
Centene Corporation
Highmark Ventures
CareSource
Valtruis
CVS Health Ventures
121G
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Wayspring on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Wayspring’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









